What to know about the FDA-approved blood test for colon cancer detection 03:33. The Food and Drug Administration approved a blood test intended to detect colorectal cancer on Monday, expanding ...

A clinical trial is launching to test the effectiveness of new tests that aim to detect genetic signatures of cancer in the blood.

The United States Food and Drug Administration (FDA) approved a new blood test to screen for colon cancer on July 29. The test from Guardant Health called Shield is not intended to replace ...

The FDA on Monday approved a blood test to screen for colorectal cancer among those aged 45 and older with an "average risk." The test was approved for people aged 45 and older with an "average ...

The FDA on Monday approved a blood test to screen for colorectal cancer among those aged 45 and older with an "average risk." The test was approved for people aged 45 and older with an "average ...

A national pilot study designed to determine if blood tests can help detect cancers earlier is open for enrollment.Results of ...

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that patient enrollment has begun ...

The recommended age to start screening for colorectal cancer was lowered in 2021 from 50 to 45 for people of average risk.

A test developed by a Madison company to better track cancer DNA in the blood stream will now be covered by Medicare.

The U.S. Food and Drug Administration has approved a new blood test to screen for colon cancer in people considered “average risk.” Guardant Health, the California company that created the ...